Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction

Haemostasis

Volumn 30, Issue 3, 2000, Pages 139-148

  Cauwenberghs, Nancy ^a   Ajzenberg, N ^c   Vauterin, S ^a   Hoylaerts, M F ^b   Declerck, P J ^a   Baruch, D ^c   Deckmyn, H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c INSERM   (France)

Author keywords

Botrocetin; Glycoprotein Ib; Monoclonal antibody; Ristocetin; Shear stress; Von Willebrand factor

Indexed keywords

BOTROCETIN; COLLAGEN TYPE 1; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; RISTOCETIN; VON WILLEBRAND FACTOR;

ANTIBODY COMBINING SITE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

EID: 0033803387     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022536     Document Type: Article

References (39)

1. Savage B, Almus-Jacobs F, Ruggeri ZM: Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998;94:657-666.
2. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL: Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987;69: 625-628.
3. Deckmyn H, Chew SL, Vermylen J: Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: A novel cause of acquired qualitative platelet dysfunction. Thromb Haemost 1990;64:74-79.
4. Kehrel B: Platelet-collagen interactions. Semin Thromb Hemost 1995; 21:123-129.
5. Scott JP, Montgomery RR, Retzinger GS: Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J Biol Chem 1991;266:8149-8155.
6. Hoylaerts MF, Nuyts K, Peerlinck K, Deckmyn H, Vermylen J: Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin. Biochem J 1995;306:453-463.
7. Read MS, Smith SV, Lamb MA, Brinkhous KM: Role of botrocetin in platelet agglutination: Formation of an activated complex of botrocetin and von Willebrand factor. Blood 1989;74:1031-1035.
8. De Marco L, Shapiro SS: Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent. J Clin Invest 1981;68: 321-328.
9. Ruggeri ZM: New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol 1994;31:229-239.
10. Goto S, Salomon DR, Ikeda Y, Ruggeri ZM: Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J BiolChem 1995;270:23352-23361.
11. Depraetere H, Ajzenberg N, Girma JP, Lacombe C, Meyer D, Deckmyn H, Baruch D: Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor. Blood 1998;91:3792-3799.
12. Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D: Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost 1990; 64:326-332.
13. Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM: Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 1991;266: 18172-18178.
14. Murata M, Ware J, Ruggeri ZM: Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem 1991;266: 15474-15480.
15. Siedlecki CA, Lestini BJ, Kottke Marchant KK, Eppell SJ, Wilson DL, Marchant RE: Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996;88:2939-2950.
16. Vicente V, Houghten RA, Ruggeri ZM: Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem 1990;265:274-280.
17. Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H: Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib. Thromb Haemost 1990;63: 122-126.
18. Booth WJ, Andrews RK, Castaldi PA, Berndt MC: The interaction of von Willebrand factor and the platelet glycoprotein Ib-IX complex. Platelets 1990;1:169-176.
19. Andrews RK, Lopez JA, Berndt MC: Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997;29:91-105.
20. Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM: Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 1991;30:1957-1964.
21. Fraker PJ, Speck JC: Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenyl-glycoluril. Biochem Biophys Res Commun 1978;80:849-857.
22. Girma JP, Kalafatis M, Piétu G, Lavergne JP, Chopek MW, Edgington TS, Meyer D: Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. Blood 1986; 67:1356-1366.
23. Wicki AN, Clemetson KJ: The glycoprotein Ib complex of human blood platelets. Eur J Biochem 1987;163:43-50.
24. Meyer S, Kresbach G, Haring P, Schumpp Vonach B, Clemetson KJ, Hadvary P, Steiner B: Expression and characterization of functionally active fragments of the platelet glycoprotein (GP) Ib-IX complex in mammalian cells. Incorporation of GP Ib alpha into the cell surface membrane. J Biol Chem 1993;268: 20555-20562.
25. Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H: A new and reproducible vWF:RiCoF assay. Thromb Haemost 2000;83: 107-113.
26. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
27. Puri S, Gresham C, Kao KJ: A simple quantitative assay for ristocetin cofactor activity using microtiter plate and ELISA plate reader. Thromb Res 1994;74:285-291.
28. Sakariassen KS, Aarts PA, de Groot PG, Houdijk WP, Sixma JJ: A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983;102:522-535.
29. Harsfalvi J, Stassen JM, Hoylaerts MF, Van Houtte E, Sawyer RT, Vermylen J, Deckmyn H: Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. Blood 1995;85:705-711.
30. Coller BS, Peerschke EI, Scudder LE, Sullivan CA: Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983;61: 99-110.
31. Ward CM, Andrews RK, Smith AI, Berndt MC: Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin. Biochemistry 1996;35:4929-4938.
32. Berndt MC, Du XP, Booth WJ: Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988;27:633-640.
33. Fujimura Y, Titani K, Holland LZ, Russell SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS: Von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem 1986;261:381-385.
34. Yamamoto N, Kitagawa H, Tanoue K, Yamazaki H: Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations. Thromb Res 1985;39:751-759.
35. Nishio K, Fujimura Y, Nishida S, Takeda I, Yoshioka A, Fukui H, Tomiyama Y, Kurata Y: Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced binding. Haemostasis 1991;21:353-359.
36. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, et al: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991;87:1234-1240.
37. Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC: Purification of botrocetin from Bothrops jararaca venom. Analysis of botrocetin-mediated interaction between von Willebrand factor and the human membrane glycoprotein Ib-IX complex. Biochemistry 1989;28: 8317-8326.
38. Berndt MC, Shen Y, Romo GA, Kenny JA, Lopez JA, Andrews RK: Identification of monoclonal antibody epitopes and the ristocetin-dependent binding site on the alpha-chain of the platelet GPIb-IX-V complex using canine-human chimaeras. Blood 1998;92:703a.
39. Fredrickson BJ, Dong JF, McIntire LV, Lopez JA: Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 1998;92:3684-3693.